I
485.84
7.24 (1.51%)
| 前收盘价格 | 478.60 |
| 收盘价格 | 479.65 |
| 成交量 | 1,980,959 |
| 平均成交量 (3个月) | 1,911,108 |
| 市值 | 172,536,479,744 |
| 市盈率 (P/E TTM) | 61.73 |
| 预期市盈率 (P/E Forward) | 49.26 |
| 价格/销量 (P/S) | 17.51 |
| 股市价格/股市净资产 (P/B) | 9.68 |
| 52周波幅 | |
| 利润日期 | 21 Apr 2026 |
| 营业毛利率 | 28.41% |
| 营业利益率 (TTM) | 25.66% |
| 稀释每股收益 (EPS TTM) | 6.81 |
| 季度收入增长率 (YOY) | 19.20% |
| 季度盈利增长率 (YOY) | 28.20% |
| 总债务/股东权益 (D/E MRQ) | 0.88% |
| 流动比率 (MRQ) | 4.98 |
| 营业现金流 (OCF TTM) | 2.73 B |
| 杠杆自由现金流 (LFCF TTM) | 1.66 B |
| 资产报酬率 (ROA TTM) | 8.84% |
| 股东权益报酬率 (ROE TTM) | 15.96% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 看跌 |
| Medical Instruments & Supplies (全球的) | 混合的 | 看跌 | |
| 股票 | Intuitive Surgical, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
1.0
| 分析师共识 | 5.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.00 |
|
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Large Growth |
| 内部持股比例 | 0.52% |
| 机构持股比例 | 89.06% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 750.00 (Bernstein, 54.37%) | 购买 |
| 中 | 635.00 (30.70%) | |
| 低 | 550.00 (Evercore ISI Group, 13.21%) | 保留 |
| 平均值 | 640.80 (31.90%) | |
| 总计 | 8 购买, 2 保留 | |
| 平均价格@调整类型 | 531.76 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Freedom Capital Markets | 27 Jan 2026 | 610.00 (25.56%) | 购买 | 525.04 |
| TD Cowen | 27 Jan 2026 | 660.00 (35.85%) | 购买 | 525.04 |
| Barclays | 26 Jan 2026 | 712.00 (46.55%) | 购买 | 528.81 |
| 07 Jan 2026 | 686.00 (41.20%) | 购买 | 592.27 | |
| BTIG | 23 Jan 2026 | 616.00 (26.79%) | 购买 | 523.99 |
| 07 Jan 2026 | 616.00 (26.79%) | 购买 | 592.27 | |
| Bernstein | 23 Jan 2026 | 750.00 (54.37%) | 购买 | 523.99 |
| 09 Jan 2026 | 740.00 (52.31%) | 购买 | 586.24 | |
| Citigroup | 23 Jan 2026 | 590.00 (21.44%) | 保留 | 523.99 |
| 11 Dec 2025 | 635.00 (30.70%) | 保留 | 547.36 | |
| Evercore ISI Group | 23 Jan 2026 | 550.00 (13.21%) | 保留 | 523.99 |
| Piper Sandler | 23 Jan 2026 | 620.00 (27.61%) | 购买 | 523.99 |
| Truist Securities | 18 Dec 2025 | 650.00 (33.79%) | 购买 | 561.89 |
| RBC Capital | 17 Dec 2025 | 650.00 (33.79%) | 购买 | 556.86 |
| 显示更多 | ||||
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BROSIUS MARK | - | 495.15 | -433 | -214,400 |
| CHARLTON HENRY L | - | 495.15 | -492 | -243,614 |
| GUTHART GARY S | - | 495.15 | -1,306 | -646,666 |
| JEDDI IMAN | - | 495.15 | -309 | -153,001 |
| LOEB GARY | - | 495.15 | -172 | -85,166 |
| ROSA DAVID J. | - | 495.15 | -724 | -358,489 |
| SAMATH JAMIE | - | 495.15 | -496 | -245,594 |
| 累积净数量 | -3,932 | |||
| 累积净值 ($) | -1,946,930 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 495.15 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BROSIUS MARK | 职员 | 10 Feb 2026 | 处理 (-) | 433 | 495.15 | 214,400 |
| BROSIUS MARK | 职员 | 10 Feb 2026 | 执行期权 | 838 | - | - |
| CHARLTON HENRY L | 职员 | 10 Feb 2026 | 处理 (-) | 492 | 495.15 | 243,614 |
| CHARLTON HENRY L | 职员 | 10 Feb 2026 | 执行期权 | 1,077 | - | - |
| SAMATH JAMIE | 职员 | 10 Feb 2026 | 处理 (-) | 496 | 495.15 | 245,594 |
| SAMATH JAMIE | 职员 | 10 Feb 2026 | 执行期权 | 1,077 | - | - |
| JEDDI IMAN | 职员 | 10 Feb 2026 | 处理 (-) | 309 | 495.15 | 153,001 |
| JEDDI IMAN | 职员 | 10 Feb 2026 | 执行期权 | 838 | - | - |
| LOEB GARY | 职员 | 10 Feb 2026 | 处理 (-) | 172 | 495.15 | 85,166 |
| LOEB GARY | 职员 | 10 Feb 2026 | 执行期权 | 315 | - | - |
| GUTHART GARY S | 董事 | 10 Feb 2026 | 处理 (-) | 1,306 | 495.15 | 646,666 |
| GUTHART GARY S | 董事 | 10 Feb 2026 | 执行期权 | 2,633 | - | - |
| ROSA DAVID J. | 职员 | 10 Feb 2026 | 处理 (-) | 724 | 495.15 | 358,489 |
| ROSA DAVID J. | 职员 | 10 Feb 2026 | 执行期权 | 1,436 | - | - |
| 显示更多 | ||||||
| 日期 | 类型 | 细节 |
|---|---|---|
| 26 Jan 2026 | 公告 | Da Vinci 5 Cleared for Cardiac Procedures |
| 23 Jan 2026 | 公告 | 20 Million Patients Benefit from da Vinci Surgery Globally |
| 22 Jan 2026 | 公告 | Intuitive Announces Fourth Quarter Earnings |
| 14 Jan 2026 | 公告 | Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results |
| 10 Dec 2025 | 公告 | Intuitive Announces Expanded Indications for da Vinci SP |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合